SQZ Biotechnologies Co
(OTCPK:SQZB)
$
0.025
-0.0025 (-9.09%)
Market Cap: 737,000.00
Enterprise Value: 12.09 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 0/100 
SQZ Biotechnologies Co at Chardan Genetic Medicines Conference TranscriptOct 04, 2022- SQZ Biotechnologies Co at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 14, 2022
- SQZ Biotechnologies Co at Jefferies Healthcare Conference TranscriptJun 08, 2022
- SQZ Biotechnologies Co at Bank of America Healthcare Conference TranscriptMay 10, 2022
- SQZ Biotechnologies Co Investor and Analyst Call TranscriptDec 09, 2021
- SQZ Biotechnologies Co at Cervivor Chat TranscriptOct 01, 2020
- SQZ Biotechnologies Co at Miami Global Brain Tumor Symposium TranscriptMay 27, 2020
SQZ Biotechnologies Co at Miami Global Brain Tumor Symposium Transcript
May 27, 2020 / 09:00PM GMT
Michael Ivan
University of Miami - Assistant Professor, Neurosurgery, Director of Research, The Brain Tumor Initiative, Chief of Service, Cranial & Neuro-oncology, Jackson South Community Hospital, & Co-chair of Neurosurgery, Jackson South Community Hospital
You guys hear me?
Unidentified Participant
Yeah.
Michael Ivan
University of Miami - Assistant Professor, Neurosurgery, Director of Research, The Brain Tumor Initiative, Chief of Service, Cranial & Neuro-oncology, Jackson South Community Hospital, & Co-chair of Neurosurgery, Jackson South Community Hospital
Yeah, great. So welcome, everybody to this week's Miami Global Brain Tumor Symposium? I am Dr. Ivan, I'm one of the brain tumor specialists here at the University of Miami and Director of Research, the Brain Tumor Initiative. And also my Co-Director; Dr. Komotar, Director of the Brain Tumor Initiative and Surgical Oncology as well as the Residency Program Director; Dr. Morcos, who's one of our Co-Chairman of the [Neurosurgery Department], and Director
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers